UBS AM
ALPN

UBS AM’s Alpine Immune Sciences Inc ALPN Stock Holding History

UBS AM’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,925
Closed -$1.5M – 2900
2024
Q1 		$1.5M Buy
37,925
+25,916
+216% +$765K ﹤0.01% 1817
2023
Q4 		$229K Buy
+12,009
New +$167K ﹤0.01% 2472

UBS AM's ALPN Position: Q2 2024 in Review

UBS AM sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 37,925 shares — an estimated $1.5M sold.

UBS AM first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $1.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • UBS AM reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • UBS AM sold 37,925 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.5M.
  • UBS AM first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
  • UBS AM's Alpine Immune Sciences Inc position peaked at $1.5M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.